DSIP (Delta Sleep-Inducing Peptide): A Research Overview

Disclaimer: This content is for laboratory research purposes only. Not for human or animal use.

Editorial Note

At Optimus Labs, our educational content is developed by reviewing the available scientific literature and aims to provide balanced, evidence-based explanations of peptide research. Unless otherwise stated, the findings discussed in this article are derived primarily from laboratory and animal studies. Research involving humans remains limited for many investigational compounds, and this article should not be interpreted as medical advice or evidence of established clinical efficacy.

What Is DSIP?

DSIP stands for Delta Sleep-Inducing Peptide. It is a naturally occurring peptide made of nine amino acids: tryptophan, alanine, glycine, glycine, aspartic acid, alanine, serine, glycine, and glutamic acid — abbreviated WAGGDASGE.

It was first isolated in 1977 from the blood of sleeping rabbits. It has since been found naturally in humans as well.

The name tells you what the researchers thought they had found: a substance in the blood that induces delta-wave sleep — the slow, high-amplitude brain waves of deep sleep.

The Rabbit Experiment

To understand DSIP, you have to understand the experiment that led to its discovery.

In the 1970s, sleep researchers were chasing a specific question: is sleep driven by a chemical that circulates in the blood?

Working in Switzerland, the physiologist Marcel Monnier and colleagues ran a series of experiments on rabbits.

What they did:

• They electrically stimulated a sleep-related region of the brain in one rabbit
• They passed that rabbit’s blood to a second rabbit
• The second rabbit began showing the slow, high-amplitude delta waves of deep sleep

Think of it as a transfusion of sleep. The first rabbit’s blood carried something that put the second rabbit to sleep.

That pointed to a sleep-promoting substance carried in the blood. In 1977, Guido Schoenenberger, Monnier, and their co-workers isolated and synthesised that substance — a nine-amino-acid peptide they named delta sleep-inducing peptide.

Having a synthetic version changed everything. It made the peptide available for wider study, and over the following decades researchers explored its role not just in sleep, but in stress, body temperature, pain, and antioxidant activity.

What the Animal Research Reported

The Cat Study (1987)

Researchers injected synthetic DSIP directly into the lateral ventricle of the brain in 10 cats and monitored the sleep-wake cycle for eight hours.

What the study reported:

• A significant decrease in sleep latency — the cats fell asleep faster
• A significant increase in total sleep
• A significant increase in total slow-wave sleep
• The increase came exclusively from deep slow-wave sleep (S2) , while light slow-wave sleep (S1) decreased
• REM sleep was unaffected — total REM, REM latency, and REM episode length were no different from controls
• The effect was immediate — S2 increased to more than 50% in the first hour after injection
• The increase was maintained for seven hours before disappearing by the eighth

Think of it as a deep-sleep switch that was flipped on and stayed on for most of the night.

The Rat Study (1988)

This study asked a different question: is DSIP just something you can inject, or is it part of the body’s normal sleep machinery?

What they did: They sleep-deprived rats for four hours by placing them on a slowly rotating wheel.

What they found: Sleep deprivation caused a significant increase in growth hormone release and in the amount of slow-wave sleep. Both increases were blocked by injecting a highly specific antiserum to DSIP into the brain.

Think about what that means. When the researchers neutralised the body’s own DSIP, the normal post-sleep-deprivation rebound in slow-wave sleep and growth hormone release did not happen.

The authors concluded that DSIP may be a physiological stimulus for sleep-related growth hormone release as well as for the induction of slow-wave sleep.

The Fragility Finding

One practical finding that emerged from the animal work: DSIP has been reported to be extremely fragile.

The half-life for proteolytic split-off of tryptophan by brain slices and homogenates has been reported at 15 minutes.

Think of it as a message written in disappearing ink. This has been identified as a key consideration for any research design involving DSIP.

Proposed Mechanisms

Researchers have proposed several mechanisms based on animal and cell studies.

Met-Enkephalin Release

Research has reported that DSIP stimulates the release of Met-enkephalin — an endogenous opioid peptide — from brain synaptosomes.

What the study reported:

• DSIP at concentrations of 10⁻¹⁰ to 10⁻⁹ M induced significant Met-enkephalin release
• The release was calcium-dependent
• DSIP significantly increased calcium uptake in synaptosomes
• The effect was observed in the cortex, hypothalamus, and midbrain, and at higher concentrations in the hippocampus and thalamus — but not in the striatum

Think of it as DSIP triggering a calcium signal in certain nerve endings, causing them to release a signalling molecule. The effect was region-specific, which the authors noted as significant.

Pineal Gland Interaction

Research has reported that DSIP modulates the α1-adrenergic receptor of the rat pineal gland in its response to adrenergic agonists.

What the study reported:

• DSIP at 20–300 nM significantly enhanced N-acetyltransferase (NAT) activity induced by norepinephrine
• The effect was eliminated by prazosin — an α1-adrenergic blocker
• The authors concluded that DSIP modulates the α1-adrenergic receptor of the rat pineal

Think of it as DSIP adjusting how sensitive the pineal gland is to a signal, rather than acting as the signal itself.

Hypothalamic and Pituitary Actions

Research has reported that DSIP stimulates the release of luteinising hormone (LH) but not follicle-stimulating hormone (FSH) via a hypothalamic site of action in the rat.

What the study reported:

• Intraventricular DSIP caused a significant elevation of LH levels within 30 minutes, lasting 2 hours
• FSH levels remained unchanged
• Incubated pituitary cells did not respond to DSIP — but median eminence fragments did, releasing LHRH
• The authors suggested DSIP may play a physiological role in sleep-related LH release

Think of DSIP as acting on the hypothalamus rather than directly on the pituitary — it changes the instructions rather than executing them.

Growth Hormone Release

DSIP has been reported to stimulate growth hormone release in rats by both hypothalamic and pituitary actions.

What Researchers Should Know

Molecular specifications:

Storage:

Lyophilised powder keeps at -20°C long-term, or 2–8°C short-term. Once reconstituted, store at 2–8°C for short-term use, or aliquot and freeze at -80°C. Avoid repeated freeze-thaw cycles.

On the literature: research on DSIP includes a substantial body of animal and cell studies. It is not an approved medicine in any jurisdiction.

Frequently Asked Questions

What is DSIP?

A nine-amino-acid peptide discovered in 1977, originally isolated from the blood of sleeping rabbits.

Why is it called “delta sleep-inducing”?

Delta waves are the slow, high-amplitude brain waves of deep sleep. Early animal experiments suggested DSIP increased this type of sleep.

What did the animal research show?

Studies in cats reported decreased sleep latency and increased deep slow-wave sleep. Studies in rats suggested DSIP may be part of the body’s normal sleep-related growth hormone release mechanism.

What mechanisms have been proposed?

Research has reported Met-enkephalin release from synaptosomes, modulation of the pineal α1-adrenergic receptor, and hypothalamic effects on LH release.

How stable is DSIP?

DSIP has been reported to be fragile, with a half-life for proteolytic split-off of tryptophan reported at 15 minutes in brain tissue preparations.

How should DSIP be stored?

Lyophilised powder at -20°C long-term or 2–8°C short-term. Reconstituted at 2–8°C short-term, or aliquoted at -80°C.

Key Takeaways

• DSIP is a nine-amino-acid peptide discovered in 1977 from the blood of sleeping rabbits
• Early animal studies reported increased deep slow-wave sleep and reduced sleep latency
• Rat studies suggested DSIP may be involved in normal sleep-related growth hormone release
• Reported mechanisms include Met-enkephalin release and pineal receptor modulation
• The peptide has been reported to be fragile, with a short half-life
• It is not an approved medicine in any jurisdiction

For Research at Optimus Labs

Optimus Labs supplies DSIP 10mg and other high-purity research peptides for laboratory use, with Certificates of Analysis confirming purity and identity. Orders ship from the UK with tracked delivery.

Explore the rest of the research catalogue for related laboratory compounds, or our overview of the most popular research peptides in the UK.

References

1. Schoenenberger GA, Monnier M. (1977). Characterization of a delta-electroencephalogram (-sleep)-inducing peptide. Proc Natl Acad Sci USA. – https://pubmed.ncbi.nlm.nih.gov/265572/
2. Schoenenberger GA. (1984). Characterization, properties and multivariate functions of delta-sleep-inducing peptide (DSIP). Eur Neurol. – https://pubmed.ncbi.nlm.nih.gov/6548966/
3. Susić V, Masirević G, Totić S. (1987). The effects of delta-sleep-inducing peptide (DSIP) on wakefulness and sleep patterns in the cat. Brain Res. – https://pubmed.ncbi.nlm.nih.gov/3620931/
4. Iyer KS, et al. (1988). Evidence for a role of delta sleep-inducing peptide in slow-wave sleep and sleep-related growth hormone release in the rat. Proc Natl Acad Sci USA. – https://pubmed.ncbi.nlm.nih.gov/3368469/
5. Nakamura A, et al. (1991). Characterization of delta-sleep-inducing peptide-evoked release of Met-enkephalin from brain synaptosomes in rats. J Neurochem. – https://doi.org/10.1111/j.1471-4159.1991.tb08251.x
6. Graf MV, Schoenenberger GA. (1987). Delta sleep-inducing peptide modulates the stimulation of rat pineal N-acetyltransferase activity by involving the α1-adrenergic receptor. J Neurochem. – https://doi.org/10.1111/j.1471-4159.1987.tb05654.x
7. Iyer KS, McCann SM. (1987). Delta sleep-inducing peptide (DSIP) stimulates the release of LH but not FSH via a hypothalamic site of action in the rat. Brain Res Bull. – https://doi.org/10.1016/0361-9230(87)90069-4
8. Iyer KS, McCann SM. (1987). Delta sleep-inducing peptide (DSIP) stimulates growth hormone (GH) release in the rat by hypothalamic and pituitary actions. Peptides. – https://doi.org/10.1016/0196-9781(87)90163-x